Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
Nicotine Tob Res. 2021 Jun 8;23(7):1160-1167. doi: 10.1093/ntr/ntaa267.
Emerging heated tobacco products (HTPs) were designed to reduce exposure to toxicants from cigarette smoke (CS) by avoiding burning tobacco and instead heating tobacco. We studied the effects of short-term inhalation of aerosols emitted from HTP called IQOS, on lung damage and immune-cell recruitment to the lungs in mice.
Numerous markers of lung damage and inflammation including albumin and lung immune-cell infiltrates, proinflammatory cytokines, and chemokines were quantified in lungs and bronchoalveolar (BAL) fluid from IQOS, CS, or air-exposed (negative control) mice.
Importantly, as a surrogate marker of lung epithelial-cell damage, we detected significantly increased levels of albumin in the BAL fluid of both HTP- and CS-exposed mice compared with negative controls. Total numbers of leukocytes infiltrating the lungs were equivalent following both IQOS aerosols and CS inhalation and significantly increased compared with air-exposed controls. We also observed significantly increased numbers of CD4+IL-17A+ T cells, a marker of a T-cell immune response, in both groups compared with air controls; however, numbers were the highest following CS exposure. Finally, the numbers of CD4+RORγt+ T cells, an inflammatory T-cell subtype expressing the transcription factor that is essential for promoting differentiation into proinflammatory Th17 cells, were significantly augmented in both groups compared with air-exposed controls. Levels of several cytokines in BAL were significantly elevated, reflecting a proinflammatory milieu.
Our study demonstrates that short-term inhalation of aerosols from IQOS generates damage and proinflammatory changes in the lung that are substantially similar to that elicited by CS exposure.
Exposure of mice to IQOS, one of the candidate modified-risk tobacco products, induces inflammatory immune-cell accumulation in the lungs and augments the levels of proinflammatory cytokines and chemokines in the BAL fluid. Such an exacerbated pulmonary proinflammatory microenvironment is associated with lung epithelial-cell damage in IQOS-exposed mice, suggesting a potential association with the impairment of lung function.
新兴的加热烟草产品(HTP)旨在通过避免燃烧烟草而加热烟草来减少香烟烟雾(CS)中的有毒物质暴露。我们研究了吸入 HTPS 称为 IQOS 的气溶胶对小鼠肺部损伤和免疫细胞向肺部募集的短期影响。
从 IQOS、CS 或空气暴露(阴性对照)的小鼠的肺部和支气管肺泡(BAL)液中定量了许多肺部损伤和炎症标志物,包括白蛋白和肺免疫细胞浸润、促炎细胞因子和趋化因子。
重要的是,作为肺上皮细胞损伤的替代标志物,我们在 HTPS 和 CS 暴露的小鼠的 BAL 液中检测到白蛋白水平显著升高,与阴性对照相比。在 IQOS 气溶胶和 CS 吸入后,肺部浸润的白细胞总数相等,与空气暴露对照相比显著增加。我们还观察到与空气对照相比,两组中 CD4+IL-17A+T 细胞的数量显著增加,CD4+IL-17A+T 细胞是 T 细胞免疫反应的标志物;然而,暴露于 CS 后的数量最高。最后,与空气暴露对照相比,两组中 CD4+RORγt+T 细胞的数量显著增加,CD4+RORγt+T 细胞是表达促进炎症性 Th17 细胞分化的转录因子的炎症性 T 细胞亚型。BAL 中的几种细胞因子水平显著升高,反映了促炎环境。
我们的研究表明,短时间吸入 IQOS 气溶胶会导致肺部损伤和促炎变化,与 CS 暴露引起的变化基本相似。
暴露于 IQOS 等候选改良风险烟草产品会导致小鼠肺部炎症免疫细胞积聚,并增加 BAL 液中促炎细胞因子和趋化因子的水平。这种加剧的肺部促炎微环境与 IQOS 暴露小鼠的肺上皮细胞损伤相关,表明与肺功能障碍有关。